Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
China
· Delayed Price · Currency is CNY 22.79
+0.11 (0.49%)
Mar 10, 2026, 3:04 PM CST
SHE:002262 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 23,038 | 24,744 | 27,326 | 24,736 | 15,769 | 16,092 | Upgrade
|
| Market Cap Growth | 0.36% | -9.45% | 10.47% | 56.87% | -2.01% | 35.74% | Upgrade
|
| Enterprise Value | 19,090 | 20,984 | 23,972 | 21,956 | 13,322 | 13,929 | Upgrade
|
| Last Close Price | 22.68 | 23.96 | 26.33 | 23.67 | 14.85 | 15.06 | Upgrade
|
| PE Ratio | 18.73 | 21.64 | 26.35 | 27.46 | 19.77 | 22.08 | Upgrade
|
| Forward PE | 18.29 | 18.59 | 22.41 | 24.31 | 17.58 | 18.30 | Upgrade
|
| PS Ratio | 3.82 | 4.34 | 5.42 | 5.76 | 4.01 | 4.79 | Upgrade
|
| PB Ratio | 2.85 | 3.40 | 4.26 | 4.43 | 3.22 | 3.92 | Upgrade
|
| P/TBV Ratio | 2.92 | 3.50 | 4.38 | 4.49 | 3.27 | 4.00 | Upgrade
|
| P/FCF Ratio | 44.91 | 53.09 | 43.08 | 46.39 | 31.86 | 16.43 | Upgrade
|
| P/OCF Ratio | 25.15 | 27.01 | 27.10 | 28.73 | 22.49 | 12.89 | Upgrade
|
| PEG Ratio | 1.41 | 1.09 | 1.02 | 1.35 | 1.66 | 0.87 | Upgrade
|
| EV/Sales Ratio | 3.17 | 3.68 | 4.76 | 5.11 | 3.39 | 4.14 | Upgrade
|
| EV/EBITDA Ratio | 12.98 | 15.38 | 19.90 | 21.43 | 13.88 | 15.86 | Upgrade
|
| EV/EBIT Ratio | 14.95 | 17.30 | 22.41 | 24.35 | 15.72 | 17.82 | Upgrade
|
| EV/FCF Ratio | 37.21 | 45.02 | 37.79 | 41.17 | 26.91 | 14.22 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.03 | 0.05 | 0.09 | 0.09 | 0.11 | 0.04 | Upgrade
|
| Debt / FCF Ratio | 0.09 | 0.15 | 0.18 | 0.17 | 0.22 | 0.04 | Upgrade
|
| Net Debt / Equity Ratio | -0.48 | -0.51 | -0.53 | -0.52 | -0.52 | -0.54 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.72 | -2.73 | -2.81 | -2.82 | -2.66 | -2.51 | Upgrade
|
| Net Debt / FCF Ratio | -7.64 | -7.98 | -5.33 | -5.42 | -5.16 | -2.25 | Upgrade
|
| Asset Turnover | 0.70 | 0.72 | 0.73 | 0.71 | 0.75 | 0.75 | Upgrade
|
| Inventory Turnover | 1.98 | 2.40 | 2.09 | 1.57 | 1.80 | 2.16 | Upgrade
|
| Quick Ratio | 6.24 | 5.00 | 5.64 | 4.88 | 5.01 | 4.99 | Upgrade
|
| Current Ratio | 7.29 | 5.68 | 6.46 | 5.86 | 5.93 | 5.77 | Upgrade
|
| Return on Equity (ROE) | 16.19% | 16.67% | 17.25% | 16.78% | 17.72% | 18.86% | Upgrade
|
| Return on Assets (ROA) | 9.28% | 9.62% | 9.68% | 9.25% | 10.14% | 10.91% | Upgrade
|
| Return on Invested Capital (ROIC) | 27.80% | 32.44% | 33.10% | 31.80% | 34.72% | 37.47% | Upgrade
|
| Return on Capital Employed (ROCE) | 15.60% | 16.50% | 16.40% | 15.90% | 16.90% | 18.70% | Upgrade
|
| Earnings Yield | 5.34% | 4.62% | 3.79% | 3.64% | 5.06% | 4.53% | Upgrade
|
| FCF Yield | 2.23% | 1.88% | 2.32% | 2.16% | 3.14% | 6.09% | Upgrade
|
| Dividend Yield | 1.59% | 1.50% | 1.21% | 0.84% | 1.35% | 0.66% | Upgrade
|
| Payout Ratio | 29.81% | 28.31% | 19.54% | 22.51% | 12.63% | 13.98% | Upgrade
|
| Buyback Yield / Dilution | -0.61% | -0.53% | 0.53% | -0.22% | 0.24% | -0.72% | Upgrade
|
| Total Shareholder Return | 0.94% | 0.98% | 1.74% | 0.63% | 1.58% | -0.06% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.